IPOGrid
0001792581
IPO filing research

Kiromic Biopharma, Inc.

Biological Products, (No Diagnostic Substances)

ipo amended S-1/A

Kiromic Biopharma, Inc. IPO research page with SEC filing history, offering status, deal terms, structured filing extracts, company news, and comparable IPO context. Latest filing: S-1/A on 2025-02-19.

Filing Timeline

SEC EDGAR
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1 filing.
2025-02-19 · 0001437749-25-004407
S-1 filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows RW in the pre-IPO sequence.
2025-01-17 · 0001437749-25-001415
RW withdrawn
Withdrawal request
Issuer requested withdrawal of the registration statement.
Follows S-1 and ends the active registration process.
2024-04-10 · 0001558370-24-004929
S-1 filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows 424B3 in the pre-IPO sequence.
2023-06-29 · 0001558370-23-011583
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
2023-05-25 · 0001558370-23-010475
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B3 and marks the registration effective.
2023-05-19 · 9999999995-23-001487
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows S-1 and confirms the priced prospectus.
2023-05-19 · 0001558370-23-010260
S-1 filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows RW in the pre-IPO sequence.
2023-05-15 · 0001558370-23-009967
RW withdrawn
Withdrawal request
Issuer requested withdrawal of the registration statement.
Follows FWP and ends the active registration process.
2022-08-19 · 0001104659-22-092952
FWP supplemental
Free writing prospectus
Prospectus supplement or marketing filing that often updates active offering terms.
Follows FWP and supplements the active offering with updated prospectus details.
2022-07-15 · 0001104659-22-079956
FWP supplemental
Free writing prospectus
Prospectus supplement or marketing filing that often updates active offering terms.
Follows S-1/A and supplements the active offering with updated prospectus details.
2022-07-14 · 0001104659-22-079691
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1 filing.
2022-07-13 · 0001104659-22-079590
S-1 filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows 424B4 in the pre-IPO sequence.
2022-06-27 · 0001104659-22-074818
424B4 priced
Final prospectus
Final prospectus filed after pricing with final deal terms.
Follows EFFECT and confirms the priced prospectus.
2021-06-30 · 0001104659-21-087657
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows FWP and marks the registration effective.
2021-06-29 · 9999999995-21-002591
FWP supplemental
Free writing prospectus
Prospectus supplement or marketing filing that often updates active offering terms.
Follows S-1 and supplements the active offering with updated prospectus details.
2021-06-25 · 0001104659-21-085822
S-1 filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows DRS in the pre-IPO sequence.
2021-06-25 · 0001104659-21-085768
DRS filed
Draft registration statement
Draft registration filed confidentially before the public launch.
Begins the tracked draft filing sequence after 424B4.
2021-06-11 · 0001104659-21-080071
424B4 priced
Final prospectus
Final prospectus filed after pricing with final deal terms.
Follows EFFECT and confirms the priced prospectus.
2020-10-16 · 0001047469-20-005215
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows CERT and marks the registration effective.
2020-10-15 · 9999999995-20-002853
CERT inactive
CERT
Pre-IPO filing captured from the SEC submission timeline.
Follows 8-A12B in the pre-IPO sequence.
2020-10-15 · 0001354457-20-000593
8-A12B effective
Exchange Act registration
Registration filed to list the securities under the Exchange Act ahead of trading.
Follows FWP and registers the class of securities for exchange listing.
2020-10-14 · 0001104659-20-114766
FWP supplemental
Free writing prospectus
Prospectus supplement or marketing filing that often updates active offering terms.
Follows S-1/A and supplements the active offering with updated prospectus details.
2020-10-06 · 0001104659-20-112520
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1/A filing.
2020-10-06 · 0001047469-20-005120
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior FWP filing.
2020-09-03 · 0001047469-20-004750
FWP supplemental
Free writing prospectus
Prospectus supplement or marketing filing that often updates active offering terms.
Follows S-1/A and supplements the active offering with updated prospectus details.
2020-08-24 · 0001104659-20-098031
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior FWP filing.
2020-08-24 · 0001047469-20-004697
FWP supplemental
Free writing prospectus
Prospectus supplement or marketing filing that often updates active offering terms.
Follows S-1/A and supplements the active offering with updated prospectus details.
2020-08-05 · 0001104659-20-090784
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior FWP filing.
2020-08-05 · 0001047469-20-004406
FWP supplemental
Free writing prospectus
Prospectus supplement or marketing filing that often updates active offering terms.
Follows S-1/A and supplements the active offering with updated prospectus details.
2020-07-21 · 0001104659-20-085209
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1/A filing.
2020-07-13 · 0001104659-20-082923
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1 filing.
2020-06-26 · 0001047469-20-003880
S-1 filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows DRS/A in the pre-IPO sequence.
2020-05-11 · 0001193125-20-138735
DRS/A amended
Amended draft registration statement
Updated draft registration filed before the public launch.
Updates the prior DRS filing.
2020-04-08 · 0000950123-20-003172
DRS filed
Draft registration statement
Draft registration filed confidentially before the public launch.
First tracked pre-IPO filing for this issuer.
2019-11-15 · 0000950123-19-011497
Comparable Deals

20 comparable deals

Healthcare & BiotechLast 18 months
Only 0 strict matches; expanded to 20 using nearest neighbors.
Showing top 8 by similarity.
+9.1%
Median day-1
60%
Above issue
+0.7%
Median week-1
-20.9%
Downside (p10)
Attovia Therapeutics, Inc. ATTO
2026-08-05 $269M Day 1: +28.8% Wk 1: +18.6%
same SICrecent IPO
Scribe Therapeutics, Inc. SCTX
2026-07-24 $129M Day 1: +44.3% Wk 1: +37.2%
same SICrecent IPO
Odyssey Therapeutics, Inc. ODTX
2026-05-08 $279M Day 1: -8.8% Wk 1: -3.8%
same SICrecent IPO
Hemab Therapeutics Holdings, Inc. COAG
2026-05-01 $302M Day 1: +88.9% Wk 1: +43.0%
same SICrecent IPO
BlossomHill Therapeutics, Inc. BLSM
2026-08-07 $150M Day 1: +0.0% Wk 1: +0.0%
same SIC grouprecent IPO
Latigo Biotherapeutics, Inc. LTGO
2026-08-07 $346M Day 1: +1.4% Wk 1: +1.4%
same SIC grouprecent IPO
Braveheart Bio, Inc. BRVE
2026-08-06 $383M Day 1: +65.6% Wk 1: +66.7%
same SIC grouprecent IPO
Apnimed, Inc. APMD
2026-07-31 $192M Day 1: +43.6% Wk 1: +74.3%
same SIC grouprecent IPO

Recent News

No recent news stored for this issuer.